+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regenerative Medicine Market Research Report by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857893
  • Report
  • July 2021
  • Region: Global
  • 183 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Regenerative Medicine Market will Grow to USD 41.56 Billion by 2026, at a CAGR of 19.94%

FEATURED COMPANIES

  • Allergan plc
  • Gilead Sciences, Inc.
  • Mimedx Group
  • Organogenesis Inc.
  • Smith & Nephew plc
  • Vericel Corporation
  • MORE
The Global Regenerative Medicine Market size was estimated at USD 13.95 Billion in 2020 and expected to reach USD 16.69 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 19.94% to reach USD 41.56 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Regenerative Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Regenerative Medicine Market was studied across Diabetes, Musculoskeletal Disorders, Ocular Disorders, Oncology, Wound Care, and Cardiovascular.
  • Based on Type, the Regenerative Medicine Market was studied across Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule and Biologic, and Tissue-Engineered Products. The Cell-Based Immunotherapy & Cell Therapy Products is further studied across Allogeneic Products and Autologous Products.
  • Based on Region, the Regenerative Medicine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Regenerative Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Regenerative Medicine Market, including Allergan plc, Amgen Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc., Smith & Nephew plc, Stryker Corporation, Takeda Pharmaceutical Co. Ltd., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Regenerative Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Regenerative Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Regenerative Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Regenerative Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Regenerative Medicine Market?
6. What is the market share of the leading vendors in the Global Regenerative Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Regenerative Medicine Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • Gilead Sciences, Inc.
  • Mimedx Group
  • Organogenesis Inc.
  • Smith & Nephew plc
  • Vericel Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
5.1.1.2. Technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials
5.1.1.3. Product approval coupled with rising government investments in regenerative medicine research
5.1.2. Restraints
5.1.2.1. Ethical issues related to the use of embryonic stem cells in R&D
5.1.3. Opportunities
5.1.3.1. Growing demand for organ transplantation and bone grafting
5.1.3.2. Increasing R&D activities by private players coupled with the involvement of academic institutes for research
5.1.4. Challenges
5.1.4.1. Regulatory issues pertaining to stem cell, tissues engineering and regenerative medicine
5.1.4.2. High cost associated with treatment
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Regenerative Medicine Market, by Application
6.1. Introduction
6.2. Diabetes
6.3. Musculoskeletal Disorders
6.4. Ocular Disorders
6.5. Oncology
6.6. Wound Care
6.7. Cardiovascular

7. Regenerative Medicine Market, by Type
7.1. Introduction
7.2. Cell-Based Immunotherapy & Cell Therapy Products
7.2.1. Allogeneic Products
7.2.2. Autologous Products
7.3. Gene Therapy Products
7.4. Small Molecule and Biologic
7.5. Tissue-Engineered Products

8. Americas Regenerative Medicine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Regenerative Medicine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Regenerative Medicine Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Allergan plc
12.2. Amgen Inc.
12.3. Gilead Sciences, Inc.
12.4. Integra LifeSciences Holdings Corporation
12.5. Medtronic Plc
12.6. Mimedx Group
12.7. Novartis AG
12.8. Organogenesis Inc.
12.9. Osiris Therapeutics, Inc.
12.10. Smith & Nephew plc
12.11. Stryker Corporation
12.12. Takeda Pharmaceutical Co. Ltd.
12.13. Vericel Corporation
12.14. Wright Medical Group N.V.
12.15. Zimmer Biomet Holdings Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL REGENERATIVE MEDICINE MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2026
FIGURE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2026
FIGURE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. CANADA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. MEXICO REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. CHINA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. INDIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. JAPAN REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. THAILAND REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. FRANCE REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. GERMANY REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. ITALY REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. QATAR REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SPAIN REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. GLOBAL REGENERATIVE MEDICINE MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL REGENERATIVE MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REGENERATIVE MEDICINE MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL REGENERATIVE MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. CANADA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. MEXICO REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CHINA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. JAPAN REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. THAILAND REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. FRANCE REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. GERMANY REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. ITALY REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. QATAR REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SPAIN REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. GLOBAL REGENERATIVE MEDICINE MARKET: SCORES
TABLE 48. GLOBAL REGENERATIVE MEDICINE MARKET: BUSINESS STRATEGY
TABLE 49. GLOBAL REGENERATIVE MEDICINE MARKET: PRODUCT SATISFACTION
TABLE 50. GLOBAL REGENERATIVE MEDICINE MARKET: RANKING
TABLE 51. GLOBAL REGENERATIVE MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 52. GLOBAL REGENERATIVE MEDICINE MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL REGENERATIVE MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL REGENERATIVE MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL REGENERATIVE MEDICINE MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL REGENERATIVE MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL REGENERATIVE MEDICINE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Allergan plc
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic Plc
  • Mimedx Group
  • Novartis AG
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Takeda Pharmaceutical Co. Ltd.
  • Vericel Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll